Patents by Inventor Larry A. McNichols
Larry A. McNichols has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7708731Abstract: An electrotransport device (10) for delivering therapeutic agents includes an adjustable voltage boos multiple controller (100, 200) for boosting the voltage from a power source (102, 202) to a working voltage Vw having a value just sufficient to provide the desired therapeutic current level II through the electrodes (108, 112), at least of which contains the therapeutic agent to be delivered.Type: GrantFiled: November 30, 2004Date of Patent: May 4, 2010Assignee: Alza CorporationInventors: Thomas A. Riddle, Larry A. McNichols, John D. Badzinski
-
Publication number: 20100076368Abstract: An electrotransport device for delivering one or more therapeutic agents through the skin includes electrodes for contacting the skin, at least one electrode containing the agent, a power source for generating electrical current (IL) for delivering the agent, a current generating and controlling means and a disabling means for permanently and irreversibly disabling the current. The disabling means may include a timer means, a counter means, or a body parameter sensor and limit comparator to effect permanent disabling. The disabling means may be a permanent transition to a disabled logic state, a permanent discharge of a power supply source, or a permanent diversion of electrotransport current from the electrodes, or a combination of the above.Type: ApplicationFiled: November 30, 2009Publication date: March 25, 2010Applicant: ALZA CorporationInventors: Larry A. McNichols, John D. Badzinski, William N. Reining, Gary A. Lattin, Ronald P. Haak, Joseph B. Phipps
-
Patent number: 7660627Abstract: An electrotransport device for delivering one or more therapeutic agents through the skin includes electrodes for contacting the skin, at least one electrode containing the agent, a power source for generating electrical current (IL) for delivering the agent, a current generating and controlling means and a disabling means for permanently and irreversibly disabling the current. The disabling means may include a timer means, a counter means, or a body parameter sensor and limit comparator to effect permanent disabling. The disabling means may be a permanent transition to a disabled logic state, a permanent discharge of a power supply source, or a permanent diversion of electrotransport current from the electrodes, or a combination of the above.Type: GrantFiled: January 18, 2006Date of Patent: February 9, 2010Assignee: ALZA CorporationInventors: Larry A. McNichols, Joseph B. Phipps, Gary A. Lattin, John D. Badzinski, Wiliam N. Reining, Ronald P. Haak
-
Publication number: 20060184093Abstract: A reservoir and a family of reservoirs are provided which are designed to be used with a single controller to provide a wide range of therapeutic drug delivering regimens while maintaining many of the same reservoir configurations and drug formulations. A method of making a reservoir and a family of reservoirs and incorporating them into an electrotransport system is disclosed.Type: ApplicationFiled: February 7, 2006Publication date: August 17, 2006Applicant: ALZA CorporationInventors: Joseph Phipps, Gary Lattin, Larry McNichols, John Badzinski
-
Publication number: 20060116662Abstract: An electrotransport device for delivering one or more therapeutic agents through the skin includes electrodes for contacting the skin, at least one electrode containing the agent, a power source for generating electrical current (IL) for delivering the agent, a current generating and controlling means and a disabling means for permanently and irreversibly disabling the current. The disabling means may include a timer means, a counter means, or a body parameter sensor and limit comparator to effect permanent disabling. The disabling means may be a permanent transition to a disabled logic state, a permanent discharge of a power supply source, or a permanent diversion of electrotransport current from the electrodes, or a combination of the above.Type: ApplicationFiled: January 18, 2006Publication date: June 1, 2006Inventors: Larry McNichols, John Badzinski, William Reining, Gary Lattin, Ronald Haak, Joseph Phipps
-
Patent number: 7054683Abstract: A reservoir and a family of reservoirs are provided which are designed to be used with a single controller to provide a wide range of therapeutic drug delivering regimens while maintaining many of the same reservoir configurations and drug formulations. A method of making a reservoir and a family of reservoirs and incorporating them into an electrotransport system is disclosed.Type: GrantFiled: August 29, 2005Date of Patent: May 30, 2006Assignee: Alza CorporationInventors: Joseph B. Phipps, Gary A. Lattin, Larry A. McNichols, John D. Badzinski
-
Patent number: 7027859Abstract: An electrotransport device (20) for delivering one or more therapeutic agents through the skin includes electrodes (30,32) for contacting the skin (34), at least one electrode containing the agent, a power source (22) for generating electrical current (IL) for delivering the agent, a current generating and controlling means (24), and a disabling means (26) for permanently and irreversibly disabling the current. The disabling means (26) may include a timer means (66), a counter means (82), or a body parameter sensor (134) and limit comparator (132) to effect permanent disabling. The disabling means may be a permanent transition to a disabled logic state, a permanent discharge of a power supply source (22), or a permanent diversion of electrotransport current from the electrodes (30,32), or a combination of the above.Type: GrantFiled: September 26, 1994Date of Patent: April 11, 2006Assignee: ALZA CorporationInventors: Larry A. McNichols, John D. Badzinski, William N. Reining, Gary A. Lattin, Ronald P Haak, Joseph B. Phipps
-
Publication number: 20050288621Abstract: A reservoir and a family of reservoirs are provided which are designed to be used with a single controller to provide a wide range of therapeutic drug delivering regimens while maintaining many of the same reservoir configurations and drug formulations. A method of making a reservoir and a family of reservoirs and incorporating them into an electrotransport system is disclosed.Type: ApplicationFiled: August 29, 2005Publication date: December 29, 2005Applicant: Alza CorporationInventors: Joseph Phipps, Gary Lattin, Larry McNichols, John Badzinski
-
Patent number: 6975902Abstract: A reservoir and a family of reservoirs are provided which are designed to be used with a single controller to provide a wide range of therapeutic drug delivering regimens while maintaining many of the same reservoir configurations and drug formulations. A method of making a reservoir and a family of reservoirs and incorporating them into an electrotransport system is disclosed.Type: GrantFiled: June 27, 2003Date of Patent: December 13, 2005Assignee: ALZA CorporationInventors: Joseph B. Phipps, Gary A. Lattin, Larry A. McNichols, John D. Badzinski
-
Publication number: 20050075623Abstract: An electrotransport device (10) for delivering therapeutic agents includes an adjustable voltage boos multiple controller (100, 200) for boosting the voltage from a power source (102, 202) to a working voltage VW having a value just sufficient to provide the desired therapeutic current level II through the electrodes (108, 112), at least of which contains the therapeutic agent to be delivered.Type: ApplicationFiled: November 30, 2004Publication date: April 7, 2005Inventors: Thomas Riddle, Larry McNichols, John Badzinski
-
Patent number: 6842640Abstract: An electrotransport device (10) for delivering therapeutic agents includes and adjustable voltage boost multiple controller (100, 200) for boosting the voltage from a power source (102, 202) to a working voltage VW having a value just sufficient to provide the desired therapeutic current level II through the electrodes (108, 112), at least of which contains the therapeutic agent to be delivered.Type: GrantFiled: September 25, 2002Date of Patent: January 11, 2005Assignee: ALZA CorporationInventors: Thomas A. Riddle, Larry A. McNichols, John D. Badzinski
-
Publication number: 20040082901Abstract: A reservoir and a family of reservoirs are provided which are designed to be used with a single controller to provide a wide range of therapeutic drug delivering regimens while maintaining many of the same reservoir configurations and drug formulations. A method of making a reservoir and a family of reservoirs and incorporating them into an electrotransport system is disclosed.Type: ApplicationFiled: June 27, 2003Publication date: April 29, 2004Inventors: Joseph B. Phipps, Gary A. Lattin, Larry A. McNichols, John D. Badzinski
-
Publication number: 20030018296Abstract: An electrotransport device (10) for delivering therapeutic agents includes an adjustable voltage boost multiple controller (100, 200) for boosting the voltage from a power source (102, 202) to a working voltage Vw having a value just sufficient to provide the desired therapeutic current level Il, through the electrodes (108, 112), at least of which contains the therapeutic agent to be delivered.Type: ApplicationFiled: September 25, 2002Publication date: January 23, 2003Inventors: Thomas A. Riddle, Larry A. McNichols, John D. Badzinski
-
Publication number: 20020087193Abstract: An electrotransport device (10) for delivering therapeutic agents includes an adjustable voltage boost multiple controller (100, 200) for boosting the voltage from a power source (102, 202) to a working voltage VW having a value just sufficient to provide the desired therapeutic current level II through the electrodes (108, 112), at least one of which contains the therapeutic agent to be delivered.Type: ApplicationFiled: December 26, 2001Publication date: July 4, 2002Inventors: Thomas A. Riddle, Larry A. McNichols, John D. Badzinski
-
Patent number: 6175763Abstract: An electrotransport system (20) for delivery of a drug through the skin (63) of a patient includes a tactile signal generator (36) for generating and transmitting a tactile signal to the skin of a patient upon the occurrence of an event associated with the operation of the system. The tactile signal may be an electric AC signaling current (Sr, Sp) applied through the skin, ie, an electric current different from the therapeutic electrotransport drive current. The electric signaling current is preferably a pulsed current of sufficient frequency and amplitude to allow the patient to feel it. The tactile signal may alternatively be generated by an electromechanical device in contact with the skin such as a piezoelectric vibrating element or magnetodynamic element such as a solenoid driven pin. The waveform of the tactile signaling current preferably has a zero average current component such that no net therapeutic drug is delivered by the tactile signal current.Type: GrantFiled: March 29, 1996Date of Patent: January 16, 2001Assignee: Alza CorporationInventors: Paul D. Sorenson, Gary A. Lattin, Larry A. McNichols
-
Patent number: 6090095Abstract: An electrotransport delivery device (410) includes control circuitry for discontinuously delivering a beneficial agent (eg, a drug) through a body surface (eg, skin 400). For example, the device may be the type which is manually activated by the patient or other medical personnel to activate electrotransport drug delivery. Once electrotransport delivery has been activated, a timer (221) counts a transition interval, typically about one minute, during which the device is allowed to operate and the impedance of the body surface (400) is allowed to stabilize. Thereafter, the electrotransport current and voltage are then monitored and compared to predetermined limits. Allowing for the transition interval permits tighter tolerances in monitoring the applied current.Type: GrantFiled: June 24, 1997Date of Patent: July 18, 2000Assignee: ALZA CorporationInventors: Larry A. McNichols, John D. Badzinski, Ronald P. Haak
-
Patent number: 6086572Abstract: A two-part electrotransport drug delivery device (20) is comprised of a controller (22) which has a plurality of different electronic outputs. The controller (22) is adapted to be mechanically and electrically coupled to a plurality of different drug-containing units (24). Each drug unit (24) includes a means (40, 42, Rx, Cx) for signaling the controller (22). The signal is read by the controller (22) and a predetermined electronic output is thereby selected and applied through the drug unit (24) in order to deliver the drug contained therein by electrotransport. The signal sent by the drug unit (24) to the controller (22) may be an optical signal (e.g., reflected light), a signal sent by an electro-mechanical connector, an electrical signal (e.g., resistance or capacitance), a magnetic signal or a metal detector sensing signal.Type: GrantFiled: March 9, 1998Date of Patent: July 11, 2000Assignee: ALZA CorporationInventors: Susan A. Johnson, Gary A. Lattin, Larry A. McNichols
-
Patent number: 6035234Abstract: An electrotransport device (10) for delivering therapeutic agents includes an adjustable voltage boost multiple controller (100, 200) for boosting the voltage from a power source (102, 202) to a working voltage V.sub.w having a value just sufficient to provide the desired therapeutic current level I.sub.I through the electrodes (108, 112), at least one of which contains the therapeutic agent to be delivered.Type: GrantFiled: September 29, 1997Date of Patent: March 7, 2000Assignee: Alza CorporationInventors: Thomas A. Riddle, Larry A. McNichols, John D. Badzinski
-
Patent number: 5978701Abstract: A two-part electrotransport drug delivery device (20) is comprised of a controller (22) which has a plurality of different electronic outputs. The controller (22) is adapted to be mechanically and electrically coupled to a plurality of different drug-containing units (24). Each drug unit (24) includes a means (40, 42, Rx, Cx) for signaling the controller (22). The signal is read by the controller (22) and a predetermined electronic output is thereby selected and applied through the drug unit (24) in order to deliver the drug contained therein by electrotransport. The signal sent by the drug unit (24) to the controller (22) may be an optical signal (eg, reflected light), a signal sent by an electro-mechanical connector, an electrical signal (eg, resistance or capacitance), a magnetic signal or a metal detector sensing signal.Type: GrantFiled: June 2, 1995Date of Patent: November 2, 1999Assignee: ALZA CorporationInventors: Susan A. Johnson, Gary A. Lattin, Larry A. McNichols
-
Patent number: 5697896Abstract: An electrotransport delivery device (410) includes control circuitry for discontinuously delivering a beneficial agent (eg, a drug) through a body surface (eg, skin 400). For example, the device may be the type which is manually activated by the patient or other medical personnel to activate electrotransport drug delivery. Once electrotransport delivery has been activated, a timer (221) counts a transition interval, typically about one minute, during which the device is allowed to operate and the impedance of the body surface (400) is allowed to stabilize. Thereafter, the electrotransport current and voltage are then monitored and compared to predetermined limits. Allowing for the transition interval permits tighter tolerances in monitoring the applied current.Type: GrantFiled: December 8, 1994Date of Patent: December 16, 1997Assignee: Alza CorporationInventors: Larry A. McNichols, John D. Badzinski, Ronald P. Haak